Difference between revisions of "Sponsors/GenScript"

Line 45: Line 45:
 
<div class="twoColumns">
 
<div class="twoColumns">
  
−
<h2>GenScript Call for Proposals </h2>  
+
<h2>GenScript Call for Corporate Innovation Proposals </h2>  
  
 
<h3>Proposals due May 1, 2016</h3>
 
<h3>Proposals due May 1, 2016</h3>

Revision as of 22:36, 17 March 2016

Special promotion for 2016 iGEM teams: receive 20% off Gene Synthesis and Cloning services!

GenScript is proud to be a sponsor for iGEM 2016!

Since 2009, GenScript has celebrated the accomplishments of many iGEM teams as they create innovative projects that accelerate the field of synthetic biology. In 2016, GenScript is excited to partner with iGEM again and provide special discounts to participating teams.

This year, all iGEM teams can receive 20% off gene synthesis and cloning services. This special promotion ends on October 31, 2016, so request your services soon!

Curious about CRISPR? Want to learn more?

Download our free CRISPR Handbook!

Want to learn more about Gene Synthesis and Molecular Cloning?

Download our free Gene Synthesis Handbook!

GenScript Call for Corporate Innovation Proposals

Proposals due May 1, 2016

Is your iGEM team looking to use the hottest gene editing technology to advance important research and clinical problems? The CRISPR/Cas9 technology has quickly revolutionized gene editing, with significant implications on the advancement of synthetic biology. In 2016, GenScript is calling for iGEM team proposals that enable CRISPR/Cas9 in the development of biologically useful model systems and tools.

Learn more about how to apply for GenScript’s CRISPR/Cas9 iGEM team funding opportunity!

Since its establishment in 2002, GenScript has been a leading provider of gene synthesis services to support life science research, translational biomedical research, and early stage pharmaceutical development. GenScript’s custom gene synthesis has accelerated synthetic biology research in many facets, from protein engineering to metabolic engineering, and more recently CRISPR genome editing. As one of the first companies to license CRISPR/Cas9 products from the Broad Institute, GenScript strives to support high quality CRISPR/Cas9 services and materials to support scientists harness the power of CRISPR genome editing in their research.

Call for Proposal Details

In 2016, GenScript seeks to support iGEM teams to advance the application of CRISPR/Cas9 in synthetic biology. Examples of projects GenScript is seeking to fund include:

  • Developing new CRISPR gRNA design tools;
  • Engineering CRISPR to power therapeutics development;
  • Harnessing CRISPR for more accurate genome editing in organisms other than mammalian, such as yeast, bacteria, plants, etc.

Reward Details

Awarded teams will receive a grant of up to $5,000 USD. Up to 10 teams will be awarded.

Proposal and application

Interested iGEM teams may submit a proposal with the following:

  1. A description of the intended project: maximum of 2 pages with a 100 word executive summary
  2. The potential applications and implications of the project

Please email the proposal to igem (at) genscript (dot) com by May 1, 2016 for consideration.


APPLY HERE!

Teams will be notified of their award by May 30, 2016. Teams will be notified of their award by May 30, 2016, and funds will be available to the teams by June 30, 2016.

For more information, please send your questions to igem (at) genscript (dot) com.